Healthcare / Medical Care FacilitiesBSE
$36.72
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-59.7M · quality 65.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$500M
P/E
11.9x
↓EV/EBITDA
6.2x
↓ROE
9.9%
↑Gross Margin
52.9%
↑Debt/Equity
0.16
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+6.4%
FCF CAGR
—
FCF margin
-17.2%
FCF / Net income
-1.94x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $474.4M · net income $42.1M · FCF $-81.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $474.4M | $474.4M | $478.5M | $430.4M | $393.4M |
| Net Income | $42.1M | $42.1M | $42.1M | $52.5M | $47.6M |
| EBITDA | $89.1M | $89.1M | $84.7M | $88.5M | $74.3M |
| EPS | — | — | 4.03 | 3.86 | 3.50 |
| Gross Margin | 52.9% | 52.9% | 51.3% | 53.1% | 52.2% |
| Operating Margin | 11.5% | 11.5% | 12.7% | 16.9% | 17.1% |
| Net Margin | 8.9% | 8.9% | 8.8% | 12.2% | 12.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.16 | 0.16 | 0.19 | 0.53 | 0.65 |
| Current Ratio | 2.22 | 2.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-81.5M | $-81.5M | $-59.7M | $-19.3M | $-53.2M |
| Returns | |||||
| ROE | 9.9% | 9.9% | 10.6% | 30.6% | 40.3% |
| Valuation | |||||
| P/E | 11.88 | 11.88 | 8.25 | — | — |
| EV/EBITDA | 6.15 | 6.15 | 3.51 | — | — |
| P/B | 1.18 | 1.18 | 0.87 | — | — |
| Growth & Yield | |||||
| Revenue Growth | -0.9% | -0.9% | 11.2% | 9.4% | — |
| EPS Growth | — | — | 4.5% | 10.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-5.7%
Start / end P/E
n/dx → n/dx
EPS bridge
4.03 → n/d
Residual
-5.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.